Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit
نویسندگان
چکیده
منابع مشابه
Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit.
BACKGROUND Erythropoietin (EPO) may improve cardiac function and induce neovascularisation in experimental models of chronic heart failure (CHF). However, the increased haematocrit associated with EPO treatment might exert concomitant deleterious effects. AIM To investigate the haematocrit independent effects of EPO on cardiac function. METHODS AND RESULTS Rats underwent permanent coronary ...
متن کاملErythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
OBJECTIVES We assessed the effects of erythropoietin (EPO) treatment in a rat model of post-myocardial infarction (MI) heart failure. BACKGROUND Erythropoietin, traditionally known as a hematopoietic hormone, has been linked to neovascularization. Whereas administration of EPO acutely after MI reduces infarct size and improves cardiac function, its role in the failing heart is unknown. METH...
متن کاملGinsenoside Rb1 improves cardiac function and remodeling in heart failure
We investigated the effect of ginsenoside Rb1 on cardiac function and remodeling in heart failure (HF). Four weeks after HF induction, the rats were administrated with ginsenoside Rb1 (35 and 70 mg/kg) and losartan (4.5 mg/kg) for 8 weeks. Losartan was used as a positive control. Cardiac function was assessed by measuring hemodynamic parameters. Histological changes were analyzed by HE and Mass...
متن کاملLow-dose simvastatin improves survival and ventricular function via eNOS in congestive heart failure.
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase endothelial nitric oxide synthase (eNOS) activity by multiple mechanisms. We previously reported that genetic overexpression of eNOS improves survival and cardiac function in congestive heart failure (CHF). In the present study, we tested the hypothesis that low-dose treatment with an 3-hydroxy-3-methylglutaryl coenzyme A reduc...
متن کاملMetoprolol improves endothelial function in patients with cardiac syndrome X
Endothelial dysfunction which is manifested by the loss of nitric oxide bioavailability, is an increasingly recognized cause of cardiac syndrome X (CSX) and beta blockers are used for the treatment of this syndrome. Thus, the aim of this study was to investigate effects of metoprolol, as a beta blocker, on endothelial function in CSX patients. The study included 25 CSX patients (20 female/ 5 ma...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Heart Failure
سال: 2008
ISSN: 1388-9842
DOI: 10.1016/j.ejheart.2007.10.008